These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1402063)

  • 61. [Nationwide sensitivity surveillance of various antibiotic activities against bacteria isolated from patients with severe infections].
    Ichiyama S; Mori T; Yamaguchi K; Hayashi M; Yamanaka K; Kurokawa Y; Uehara N; Takahashi C; Negayama K; Kaneko Y; Hirakata Y
    Jpn J Antibiot; 2001 Aug; 54(8):401-47. PubMed ID: 11680053
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.
    Soussy CJ; Cluzel M; Ploy MC; Kitzis MD; Morel C; Bryskier A; Courvalin P
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis].
    Obana M; Tomizawa I; Takizawa Y; Nitta Y; Sagara H; Seo T; Sato J; Tsunoda T; Ota S; Machii A
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1165-82. PubMed ID: 1761896
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Laboratory and clinical studies on levofloxacin].
    Tanaka K; Iwamoto M; Maesaki S; Koga H; Kohno S; Hara K; Sugawara K; Kaku M; Kusano S; Sakito O
    Jpn J Antibiot; 1992 May; 45(5):548-56. PubMed ID: 1512941
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of recent antibacterial agents against bacteria causing diarrhoea.
    Bergan T; Lolekha S; Cheong MK; Poh CL; Doencham S; Charoenpipop D
    Scand J Infect Dis Suppl; 1988; 56():7-10. PubMed ID: 3266900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
    Kumada T; Neu HC
    J Antimicrob Chemother; 1985 Nov; 16(5):563-74. PubMed ID: 3865923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antimicrobial activities of ciprofloxacin against recently obtained clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1994 Sep; 47(9):1160-85. PubMed ID: 7990257
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phototoxic potential of quinolone antibacterial agents in Balb/c mice.
    Wagai N; Yamaguchi F; Sekiguchi M; Tawara K
    Toxicol Lett; 1990 Dec; 54(2-3):299-308. PubMed ID: 2260126
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro study of the antibacterial activity of ofloxacin against recent clinical isolates.
    Varoli O; Ferri M
    Drugs Exp Clin Res; 1987; 13(4):209-12. PubMed ID: 3476290
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
    Thwaites RT; Frost JA
    J Clin Pathol; 1999 Nov; 52(11):812-4. PubMed ID: 10690169
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
    Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
    Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Nationwide susceptibility surveillance of ciprofloxacin and various parenteral antimicrobials against bacteria isolated from patients with severe infections--third ciproxan injection special survey (2005)].
    Yamaguchi K; Ishii Y; Yamanaka K; Watanabe N; Uehara N; Kaku M; Okabe T; Ito K; Nagasawa M; Baba H; Ichiyama S; Kurokawa Y; Negayama K; Hirakata Y
    Jpn J Antibiot; 2008 Aug; 61(4):241-68. PubMed ID: 19024645
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.